DISCOUNT ZERTIFIKAT - INTUITIVE SURGICAL Stock

Certificat

DE000ME7CXZ9

Real-time Bid/Ask 10:57:06 2024-05-20 am EDT
203.95 EUR / 204.08 EUR +0.07% Intraday chart for DISCOUNT ZERTIFIKAT - INTUITIVE SURGICAL
Current month-1.45%
1 month-1.24%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-20 203.8 -0.02%
24-05-17 203.9 +0.08%
24-05-16 203.7 -0.00%
24-05-15 203.7 -0.48%
24-05-14 204.7 -0.20%

Delayed Quote Börse Stuttgart

Last update May 20, 2024 at 07:54 am EDT

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
Issuer Morgan Stanley
WKN ME7CXZ
ISINDE000ME7CXZ9
Date issued 2024-01-23
Cap 225 $
Last trading day 2024-09-20
Maturity 2024-09-20 (123 Days)
Parity 1 : 1
Emission price 201.6
Emission volume N/A
Payment day 2024-09-27
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 44.38 %
Sideways yield 1.477 %
Sideways yield pa 4.382 %
Outperformance point 404.5 $
Break even 220.91 €
Highest since issue 207.2
Lowest since issue 197.2
Spread 0.11
Spread %0.05%
Distance Cap 173.9 $
Distance Cap %+43.60%
Max. earning 3.013
Max. earning % 1.477 %

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
398.8 USD
Average target price
420.4 USD
Spread / Average Target
+5.41%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW